These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

520 related items for PubMed ID: 14982604

  • 1. A simple C-reactive protein measurement for the differentiation between tuberculous and malignant pleural effusion.
    Chierakul N, Kanitsap A, Chaiprasert A, Viriyataveekul R.
    Respirology; 2004 Mar; 9(1):66-9. PubMed ID: 14982604
    [Abstract] [Full Text] [Related]

  • 2. Use of pleural fluid C-reactive protein in laboratory diagnosis of pleural effusions.
    Castaño Vidriales JL, Amores Antequera C.
    Eur J Med; 1992 Mar; 1(4):201-7. PubMed ID: 1341445
    [Abstract] [Full Text] [Related]

  • 3. Antibody detection for the diagnosis of tuberculous pleuritis.
    Chierakul N, Damrongchokpipat P, Chaiprasert A, Arjratanakul W.
    Int J Tuberc Lung Dis; 2001 Oct; 5(10):968-72. PubMed ID: 11605893
    [Abstract] [Full Text] [Related]

  • 4. Acute phase markers for the differentiation of infectious and malignant pleural effusions.
    Kiropoulos TS, Kostikas K, Oikonomidi S, Tsilioni I, Nikoulis D, Germenis A, Gourgoulianis KI.
    Respir Med; 2007 May; 101(5):910-8. PubMed ID: 17270413
    [Abstract] [Full Text] [Related]

  • 5. C-reactive protein in lymphocytic pleural effusions: a diagnostic aid in tuberculous pleuritis.
    Garcia-Pachon E, Soler MJ, Padilla-Navas I, Romero V, Shum C.
    Respiration; 2005 May; 72(5):486-9. PubMed ID: 16210887
    [Abstract] [Full Text] [Related]

  • 6. Osteopontin and C-reactive protein in Egyptian patients affected with tuberculous and malignant pleural effusion.
    Elsammak M MY, Morsi TS, Khamis HI, Ragab MS, Zaki MA, Abdel-Hadi M, Hassan HA.
    Ann Clin Biochem; 2007 May; 44(Pt 3):264-72. PubMed ID: 17456294
    [Abstract] [Full Text] [Related]

  • 7. Differentiating tuberculous from malignant pleural effusions: a scoring model.
    Porcel JM, Vives M.
    Med Sci Monit; 2003 May; 9(5):CR175-80. PubMed ID: 12761453
    [Abstract] [Full Text] [Related]

  • 8. Procalcitonin as a diagnostic marker in differentiating parapneumonic effusion from tuberculous pleurisy or malignant effusion.
    Lee SH, Lee EJ, Min KH, Hur GY, Lee SY, Kim JH, Shin C, Shim JJ, In KH, Kang KH, Lee SY.
    Clin Biochem; 2013 Oct; 46(15):1484-8. PubMed ID: 23570862
    [Abstract] [Full Text] [Related]

  • 9. Validity of procalcitonin and C-reactive protein measurement when differentiating between benign and malignant pleural effusion.
    Botana-Rial M, Casado-Rey P, Leiro-Fernández V, Andrade-Olivié M, Represas-Represas C, Fernández-Villar A.
    Clin Lab; 2011 Oct; 57(5-6):373-8. PubMed ID: 21755828
    [Abstract] [Full Text] [Related]

  • 10. A simple C-reactive protein measurement for the differentiation between tuberculous and malignant pleural effusion: comment.
    Garcia-Pachon E, Padilla-Navas I, Llorca IL, Shum C.
    Respirology; 2004 Nov; 9(4):568; author reply 569. PubMed ID: 15612973
    [No Abstract] [Full Text] [Related]

  • 11. [Clinical investigation of the diagnostic value of interferon-gamma, interleukin-12 and adenosine deaminase isoenzyme in tuberculous pleurisy].
    Tian RX, Gao ZC.
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jul; 27(7):435-8. PubMed ID: 15312552
    [Abstract] [Full Text] [Related]

  • 12. Diagnosis of tuberculosis in patients with pleural effusion in an area of HIV infection and limited diagnostic facilities.
    Richter C, Perenboom R, Swai AB, Kitinya J, Mtoni I, Chande H, Kazema RR, Chuwa LM, Mwakyusa DH, Maselle SY.
    Trop Geogr Med; 1994 Jul; 46(5):293-7. PubMed ID: 7855915
    [Abstract] [Full Text] [Related]

  • 13. Vasoactive mediators (VEGF and TNF-alpha) in patients with malignant and tuberculous pleural effusions.
    Hamed EA, El-Noweihi AM, Mohamed AZ, Mahmoud A.
    Respirology; 2004 Mar; 9(1):81-6. PubMed ID: 14982607
    [Abstract] [Full Text] [Related]

  • 14. Pleural fluid adenosine deaminase and interferon gamma as diagnostic tools in tuberculosis pleurisy.
    Krenke R, Safianowska A, Paplinska M, Nasilowski J, Dmowska-Sobstyl B, Bogacka-Zatorska E, Jaworski A, Chazan R.
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():349-60. PubMed ID: 19218659
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic value of leptin in tuberculous pleural effusions.
    Celik G, Kaya A, Poyraz B, Ciledag A, Elhan AH, Oktem A, Tozkoparan E, Ozkan M.
    Int J Clin Pract; 2006 Nov; 60(11):1437-42. PubMed ID: 16669825
    [Abstract] [Full Text] [Related]

  • 16. Diagnostic significance of gamma-interferon in tuberculous pleurisy.
    Poyraz B, Kaya A, Ciledağ A, Oktem A, Gönüllü U.
    Tuberk Toraks; 2004 Nov; 52(3):211-7. PubMed ID: 15351932
    [Abstract] [Full Text] [Related]

  • 17. Pleural adenosine deaminase in the separation of transudative and exudative pleural effusions.
    Atalay F, Ernam D, Hasanoglu HC, Karalezli A, Kaplan O.
    Clin Biochem; 2005 Dec; 38(12):1066-70. PubMed ID: 16226239
    [Abstract] [Full Text] [Related]

  • 18. Diagnosis of tuberculous pleuritis by the measurement of soluble interleukin 2 receptor in pleural fluid.
    Porcel JM, Gázquez I, Vives M, Pérez B, Rubio M, Rivas MC.
    Int J Tuberc Lung Dis; 2000 Oct; 4(10):975-9. PubMed ID: 11055766
    [Abstract] [Full Text] [Related]

  • 19. Adenosine deaminase activity level as a tool for diagnosing tuberculous pleural effusion.
    Khow-Ean N, Booraphun S, Aekphachaisawat N, Sawanyawisuth K.
    Southeast Asian J Trop Med Public Health; 2013 Jul 04; 44(4):655-9. PubMed ID: 24050100
    [Abstract] [Full Text] [Related]

  • 20. Clinical utility of a combination of tumour markers in the diagnosis of malignant pleural effusions.
    Gaspar MJ, De Miguel J, García Díaz JD, Díez M.
    Anticancer Res; 2008 Jul 04; 28(5B):2947-52. PubMed ID: 19031938
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.